Obesity plays a significant role in the care of patients with gynecologic malignancy. It is the strongest risk factor for endometrial cancer. It results in delays in diagnosis and access to surgical treatment, and is a challenge in improving MIS rates in many centres. Obesity contributes significantly to post-operative length of stay and complication rates. It is associated with increased risk of recurrence and reduced cancer-specific and overall survival in endometrial cancer. Obesity is a significant survivorship issue in all gynecologic malignancies, with obesity-related co-morbidities resulting in decreased quality of life and increased mortality. Weight-loss and lifestyle interventions are scarcely available, and expedited access to bariatric surgery is limited.
A CoP in Obesity could work to address these issues in a number of ways:
To learn more about the CoP in Obesity or to become a member, contact Carine Trazo at email@example.com.